Sergey Menis
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Virology 20
- HIV Research and Treatment 20
- Immunology 15
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 6
- Co-authors
- William R. Schief (21 shared papers)Daniel W. Kulp (11 shared papers)Devin Sok (8 shared papers)Dennis R. Burton (7 shared papers)Joseph G. Jardine (5 shared papers)Oleksandr Kalyuzhniy (5 shared papers)David Nemazee (5 shared papers)Takayuki Ota (3 shared papers)
- Journals
- Science (4 papers)Nature Communications (3 papers)Immunity (2 papers)Molecular Therapy (1 paper)Pharmaceutics (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Sergey Menis
22 papers receiving 2.7k citations
Sergey Menis's Hit Papers
Peers
Comparison fields: 5 of 89
- Virology 1.4k
- Immunology 1.3k
- Infectious Diseases 557
- Radiology, Nuclear Medicine and Imaging 609
- Pharmaceutical Science 124
Countries citing papers authored by Sergey Menis
This map shows the geographic impact of Sergey Menis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Menis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Menis more than expected).
Fields of papers citing papers by Sergey Menis
This network shows the impact of papers produced by Sergey Menis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Menis. The network helps show where Sergey Menis may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergey Menis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors Hit paper breakdown → | 2013 | 552 |
| 2 | 2015 | 270 | |
| 3 | 2018 | 218 | |
| 4 | 2013 | 215 | |
| 5 | 2017 | 210 | |
| 6 | 2019 | 174 | |
| 7 | 2017 | 147 | |
| 8 | 2014 | 144 | |
| 9 | 2020 | 143 | |
| 10 | 2016 | 142 | |
| 11 | 2016 | 109 | |
| 12 | 2015 | 101 | |
| 13 | 2018 | 87 | |
| 14 | 2019 | 67 | |
| 15 | 2018 | 65 | |
| 16 | 2021 | 27 | |
| 17 | 2017 | 24 | |
| 18 | 2018 | 19 | |
| 19 | 2011 | 15 | |
| 20 | 2013 | 4 |
About Sergey Menis
Sergey Menis is a scholar working on Virology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Epidemiology, having authored 22 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV Research and Treatment (20 papers), Immune Cell Function and Interaction (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (6 papers), Glycosylation and Glycoproteins Research (4 papers), Herpesvirus Infections and Treatments (3 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Virology (1.4k citations), Immunology (1.3k citations), Infectious Diseases (557 citations), Radiology, Nuclear Medicine and Imaging (609 citations) and Pharmaceutical Science (124 citations). Sergey Menis has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include William R. Schief, Daniel W. Kulp, Devin Sok, Dennis R. Burton, Joseph G. Jardine, Oleksandr Kalyuzhniy, David Nemazee, Takayuki Ota, Darrell J. Irvine and Meaghan Jones. Their work appears in journals such as Science, Nature Communications, Immunity, Molecular Therapy and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.